These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis. Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males. Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses. Orsini JA; Moate PJ; Boston RC; Norman T; Engiles J; Benson CE; Poppenga R J Vet Pharmacol Ther; 2005 Aug; 28(4):355-61. PubMed ID: 16050815 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacokinetics of an imipenem-cilastatin combination]. Singlas E Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939 [TBL] [Abstract][Full Text] [Related]
8. Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin. Mayer M; Tophof C; Opferkuch W Infection; 1988; 16(4):225-8. PubMed ID: 3182087 [TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function. Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration. Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of imipenem/cilastatin in neutropenic patients with haematological malignancies. Janmohamed RM; Leyland MJ; Kelly J; Farrell I J Antimicrob Chemother; 1990 Mar; 25(3):407-12. PubMed ID: 2338419 [TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects. Rizk ML; Rhee EG; Jumes PA; Gotfried MH; Zhao T; Mangin E; Bi S; Chavez-Eng CM; Zhang Z; Butterton JR Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311084 [TBL] [Abstract][Full Text] [Related]
14. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation]. Pezé P; Mounier M; Cevallos R; Denis F Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446 [TBL] [Abstract][Full Text] [Related]
15. Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure. Konishi K; Suzuki H; Saruta T; Hayashi M; Deguchi N; Tazaki H; Hisaka A Antimicrob Agents Chemother; 1991 Aug; 35(8):1616-20. PubMed ID: 1929334 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus. Sundelof JG; Thompson R; White KM; Sasor MW; Cama L; Kropp H Antimicrob Agents Chemother; 1996 Mar; 40(3):795-8. PubMed ID: 8851616 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis. Bergan T; Michalsen H; Malmborg AS; Pedersen SS; Pressler T; Storrøsten OT; Strandvik B Chemotherapy; 1993; 39(6):369-73. PubMed ID: 8222862 [TBL] [Abstract][Full Text] [Related]
18. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients. Keller E; Fecht H; Böhler J; Schollmeyer P Nephrol Dial Transplant; 1989; 4(7):640-5. PubMed ID: 2510062 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation. Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549 [TBL] [Abstract][Full Text] [Related]
20. Using imipenem and cilastatin during continuous renal replacement therapy. Cotton A; Franklin BD; Brett S; Holmes A Pharm World Sci; 2005 Oct; 27(5):371-5. PubMed ID: 16341743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]